TP53 and neoplasm: In this instance, the presence of a p53 mutant immunohistochemical staining pattern suggested that her tumor may behave more aggressively despite the expansile growth pattern and drove the decision to treat with 3 cycles of adjuvant capecitabine/oxaliplatin.